Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT02797756
Eligibility Criteria:
Inclusion Criteria:
* Children (Age 0 - 24 years) referred to the NYU Pediatric AeroDigestive Center to evaluate for CC (\>4weeks).
Exclusion Criteria:
* Antibiotic or steroids (inhaled or systemic) use within the prior one-week. Rationale: Antibacterial drugs and immune-modulators are confounders that may impact the microbiome and inflammation. While longer period free of Antibacterial drugs and immune-modulators would be desired, it would be unethical and it is not the usual standard of care to withdraw treatment for longer periods of time.
* Interstitial Lung Disease or pneumonia on X-ray
* Cystic fibrosis
* Primary ciliary dyskinesia
* Immunodeficiency syndromes
* Major airway abnormalities
* Proton pump inhibitor/H2-receptor antagonist therapy within the prior 2 weeks
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
24 Years
Study:
NCT02797756
Study Brief:
Protocol Section:
NCT02797756